BPC-157
15 graded outcomes
Peptide Record
Every peptide-outcome pair here is graded A to E by a fixed rule from recorded inputs, with the arithmetic behind each letter printed beside it. Where the evidence is thin we say so. Where we have not collected something, we say that instead of leaving a blank.
| Grade | Means | Pairs | Share |
|---|---|---|---|
| Strong — replicated human trials | 6 | 6% | |
| Moderate — human evidence, limited replication | 25 | 25% | |
| Limited — small or single human studies | 13 | 13% | |
| Preliminary — animal evidence only | 40 | 39% | |
| Insufficient — preclinical or absent | 0 | 0% | |
| Not graded | Evidence collected, no design determined — we have not finished reading, which is a different claim from E | 18 | 18% |
A grade measures how much evidence exists for one outcome — not whether a compound works, and not whether it is safe. Every letter is drawn at the same size in the same ink for exactly that reason. A zero beside a letter means no pair reached it, and not graded is counted as its own row rather than left out of the denominator. How grading works
15 graded outcomes
3 graded outcomes
2 graded outcomes · carries an alias caveat
1 graded outcome
5 graded outcomes
7 graded outcomes
13 graded outcomes
8 graded outcomes
18 graded outcomes · carries an alias caveat
12 graded outcomes
The grade shown is the best any single outcome reached. It is not a grade for the peptide — nothing here grades a peptide, only a peptide against one outcome.